Sysmex Corp 6869
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥1,957.50
- Day Range
- ¥1,929.00–1,951.50
- 52-Week Range
- ¥1,246.00–2,025.00
- Bid/Ask
- ¥1,935.00 / ¥1,940.00
- Shares Outstanding
- 602.04M
- Market Cap
- ¥1.17T
- Volume/Avg
- 2M / 3M
Key Statistics
- Price/Earnings (Normalized)
- 30.06
- Price/Sales
- 2.29
- Dividend Yield (Trailing)
- 1.96%
- Dividend Yield (Forward)
- 2.07%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 4.20%
Company Profile
Sysmex Corp manufactures and sells laboratory testing equipment and reagents. It conducts product development, manufacturing, sales, and service activities in domestic markets, while certain products are also developed, manufactured, and sold through its subsidiaries. The company operates through five reportable segments based on headquarters: Head Office Management, Americas Headquarters, EMEA Headquarters, China Headquarters, and AP Headquarters.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,665
- Website
- https://www.sysmex.co.jp
Valuation
|
Metric
|
6869
|
|---|---|
Price/Earnings (Normalized) | 30.06 |
Price/Book Value | 2.41 |
Price/Sales | 2.29 |
Price/Cash Flow | 12.73 |
Price/Earnings
6869
Financial Strength
|
Metric
|
6869
|
|---|---|
Quick Ratio | 2.28 |
Current Ratio | 3.40 |
Interest Coverage | 12.52 |
Quick Ratio
6869
Profitability
|
Metric
|
6869
|
|---|---|
Return on Assets (Normalized) | 6.99% |
Return on Equity (Normalized) | 9.94% |
Return on Invested Capital (Normalized) | 9.03% |
Return on Assets
6869
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|#>>d<P | LOCK|&%>Y | $178B | |||
| Medtronic PLC
MDT
| LOCK|P^pQ?@ | LOCK|MhS? | $120B | |||
| Stryker Corp
SYK
| LOCK|@$M??TPr | LOCK|%> | $116B | |||
| Boston Scientific Corp
BSX
| LOCK|@#PGbss | LOCK|$!tM | $65B | |||
| Edwards Lifesciences Corp
EW
| LOCK|MQCWKQX? | LOCK|gd<z | $52B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|byjtyfY | LOCK|^N | $32B | |||
| DexCom Inc
DXCM
| LOCK|mmWdz@MG | LOCK|HmQ! | $30B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|<? | LOCK|ty> | $26B | |||
| Steris PLC
STE
| LOCK|wD?ylc | LOCK|SNxP% | $22B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|yRNZ%Bs! | LOCK|<# | $18B |
United States